Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus Capsules USP in the strengths of 0.5 mg, 1 mg and 5 mg, Glenmark said in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eRj1kb
via IFTTT
0 comments:
Post a Comment